KLP Kapitalforvaltning AS Acquires New Position in Avidity Biosciences, Inc. (NASDAQ:RNA)
KLP Kapitalforvaltning AS purchased a new position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 17,900 shares of the biotechnology company’s stock, valued at approximately $521,000. Other institutional investors and hedge funds […]
KLP Kapitalforvaltning AS purchased a new position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 17,900 shares of the biotechnology company’s stock, valued at approximately $521,000. Other institutional investors and hedge funds […]
